GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (BSP:B1MR34) » Definitions » Days Inventory

Biomarin Pharmaceutical (BSP:B1MR34) Days Inventory

: 723.23 (As of Dec. 2023)
View and export this data going back to 2020. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Biomarin Pharmaceutical's Average Total Inventories for the three months ended in Dec. 2023 was R$5,261 Mil. Biomarin Pharmaceutical's Cost of Goods Sold for the three months ended in Dec. 2023 was R$664 Mil. Hence, Biomarin Pharmaceutical's Days Inventory for the three months ended in Dec. 2023 was 723.23.

The historical rank and industry rank for Biomarin Pharmaceutical's Days Inventory or its related term are showing as below:

BSP:B1MR34' s Days Inventory Range Over the Past 10 Years
Min: 479.97   Med: 577.47   Max: 709.39
Current: 698.71

During the past 13 years, Biomarin Pharmaceutical's highest Days Inventory was 709.39. The lowest was 479.97. And the median was 577.47.

BSP:B1MR34's Days Inventory is ranked worse than
84.75% of 649 companies
in the Biotechnology industry
Industry Median: 190.88 vs BSP:B1MR34: 698.71

Biomarin Pharmaceutical's Days Inventory increased from Dec. 2022 (621.26) to Dec. 2023 (723.23). It might indicate that Biomarin Pharmaceutical's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Biomarin Pharmaceutical's Inventory Turnover for the three months ended in Dec. 2023 was 0.13.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biomarin Pharmaceutical's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.66.


Biomarin Pharmaceutical Days Inventory Historical Data

The historical data trend for Biomarin Pharmaceutical's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 600.38 432.09 547.75 653.29 731.74

Biomarin Pharmaceutical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 621.26 655.92 698.78 728.17 723.23

Competitive Comparison

For the Biotechnology subindustry, Biomarin Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomarin Pharmaceutical Days Inventory Distribution

For the Biotechnology industry and Healthcare sector, Biomarin Pharmaceutical's Days Inventory distribution charts can be found below:

* The bar in red indicates where Biomarin Pharmaceutical's Days Inventory falls into.



Biomarin Pharmaceutical Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biomarin Pharmaceutical's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (4689.823 + 5424.975) / 2 ) / 2522.682*365
=5057.399 / 2522.682*365
=731.74

Biomarin Pharmaceutical's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (5097.524 + 5424.975) / 2 ) / 663.815*365 / 4
=5261.2495 / 663.815*365 / 4
=723.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomarin Pharmaceutical  (BSP:B1MR34) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biomarin Pharmaceutical's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biomarin Pharmaceutical's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Biomarin Pharmaceutical Days Inventory Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomarin Pharmaceutical (BSP:B1MR34) Business Description

Traded in Other Exchanges
Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the U.S. in 2023.

Biomarin Pharmaceutical (BSP:B1MR34) Headlines

No Headlines